Get started
OOO

OnKure Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

OKUR chart


Full chart

OKUR upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪207.38 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−16.85 USD
Net income (FY)
‪−77.39 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪2.44 M‬
Beta (1Y)
−0.32

Employees


Employees (FY)
8
Change (1Y)
−40 −83.33%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−9.67 M‬ USD

About OnKure Therapeutics, Inc.


Sector
Health Technology
CEO
Nicholas A. Saccomano
Headquarters
Boulder
Website
onkuretherapeutics.com
FIGI
BBG00JVRSRC1
OnKure Therapeutics, Inc. engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure and computational chemistry driven drug design platform, committed to improving clinical outcomes for patients by building a robust pipeline of small molecule drugs designed to selectively target specific mutations thought to be key drivers of cancer. It is headquartered in Boulder, CO.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

OKUR news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of OKUR is 16.00 USD — it has decreased by −2.38% in the past 24 hours. Watch OnKure Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange OnKure Therapeutics, Inc. stocks are traded under the ticker OKUR.
OKUR stock has fallen by −5.94% compared to the previous week, the month change is a −12.57% fall, over the last year OnKure Therapeutics, Inc. has showed a −74.56% decrease.
We've gathered analysts' opinions on OnKure Therapeutics, Inc. future price: according to them, OKUR price has a max estimate of 40.00 USD and a min estimate of 31.00 USD. Watch OKUR chart and read a more detailed OnKure Therapeutics, Inc. stock forecast: see what analysts think of OnKure Therapeutics, Inc. and suggest that you do with its stocks.
OKUR reached its all-time high on Apr 9, 2021 with the price of 1,717.99 USD, and its all-time low was 9.80 USD and was reached on Dec 14, 2023. View more price dynamics on OKUR chart.
See other stocks reaching their highest and lowest prices.
OKUR stock is 3.15% volatile and has beta coefficient of −0.32. Track OnKure Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is OnKure Therapeutics, Inc. there?
Today OnKure Therapeutics, Inc. has the market capitalization of ‪54.79 M‬, it has increased by 1.77% over the last week.
Yes, you can track OnKure Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
OnKure Therapeutics, Inc. is going to release the next earnings report on Nov 21, 2024. Keep track of upcoming events with our Earnings Calendar.
OKUR earnings for the last quarter are −1.60 USD per share, whereas the estimation was −1.00 USD resulting in a −60.00% surprise. The estimated earnings for the next quarter are −1.10 USD per share. See more details about OnKure Therapeutics, Inc. earnings.
OnKure Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
OKUR net income for the last quarter is ‪−5.36 M‬ USD, while the quarter before that showed ‪−8.43 M‬ USD of net income which accounts for 36.38% change. Track more OnKure Therapeutics, Inc. financial stats to get the full picture.
No, OKUR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 8.00 employees. See our rating of the largest employees — is OnKure Therapeutics, Inc. on this list?
Like other stocks, OKUR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OnKure Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OnKure Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OnKure Therapeutics, Inc. stock shows the strong sell signal. See more of OnKure Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.